The MARCOPOLO Study of Ustekinumab Utilization and Efficacy in a Real-World Setting: Treatment of Patients with Plaque Psoriasis in Asia-Pacific Countries

BACKGROUND: Ustekinumab is a fully human monoclonal antibody approved for the treatment of chronic moderate-to-severe plaque psoriasis in adults. However, factors including efficacy, tolerability, ease of use, and cost burden may affect ustekinumab utilization. Noncompliance may, in turn, affect tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Youn, Sang Woong, Tsai, Tsen-Fang, Theng, Colin, Choon, Siew-Eng, Wiryadi, Benny E., Pires, Antonio, Tan, Weihao, Lee, Min-Geol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828387/
https://www.ncbi.nlm.nih.gov/pubmed/27081271
http://dx.doi.org/10.5021/ad.2016.28.2.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828387/
https://www.ncbi.nlm.nih.gov/pubmed/27081271
http://dx.doi.org/10.5021/ad.2016.28.2.222

Ejemplares similares